ClinicalTrials.gg
Drug

Zasocitinib clinical trials

Also written TAK-279 and NDI-034858.

studies test it
26
open now
7
in phase 3
11
first study started
2021

How each study uses zasocitinib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the zasocitinib studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Zasocitinib
13
TAK- 279
4

Development codes

TAK-279
22
NDI-034858
10

Studies by the year they started

25 studies that test it; most in 2024 (7); 1 more planned to start later

Studies that test zasocitinib, by start year
YearStudies
20211
20221
20235
20247
20257
20264

By phase

A phase 1/2 study counts in both.

Phase 1
7
Phase 2
8
Phase 3
11

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 26 · Other 0

Takeda (26)

Often tested with

Tested in the same studies.

Moxifloxacin (1) · Repaglinide (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 6, 3 in phase 3

Studies that test zasocitinib, phase 3 first.

Studies

Open first, then newest update. How each study uses zasocitinib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 26

See all 26 studies that test zasocitinib →

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call zasocitinib · ClinicalTrials.gg INT016156

  • UNII (FDA) C293MNS6TQZASOCITINIBOne source FDA
  • NCI Thesaurus C199133ZasocitinibOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.